Published in Clin Infect Dis on June 01, 1995
Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep (1998) 1.98
The social determinants of emergency department and hospital use by injection drug users in Canada. J Urban Health (1999) 1.67
Clinical care of the HIV-infected drug user. Infect Dis Clin North Am (2007) 1.30
Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. J Virol (2004) 1.23
Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor. J Investig Med (2002) 1.23
Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes. Am J Pathol (2010) 1.08
Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV. BMC Pulm Med (2010) 1.06
Methadone enhances human immunodeficiency virus infection of human immune cells. J Infect Dis (2001) 1.04
Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users. Int J Chron Obstruct Pulmon Dis (2011) 0.95
Opioids and HIV/HCV infection. J Neuroimmune Pharmacol (2011) 0.91
Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytes. J Pharmacol Exp Ther (2003) 0.91
Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission. Life Sci (2010) 0.87
Morphine suppresses IFN signaling pathway and enhances AIDS virus infection. PLoS One (2012) 0.85
Variable region 4 of SIV envelope correlates with rapid disease progression in morphine-exposed macaques infected with SIV/SHIV. Virology (2006) 0.85
Frequent food insecurity among injection drug users: correlates and concerns. BMC Public Health (2012) 0.84
Accelerated evolution of SIV env within the cerebral compartment in the setting of morphine-dependent rapid disease progression. Virology (2009) 0.82
Obstructive Lung Diseases in HIV: A Clinical Review and Identification of Key Future Research Needs. Semin Respir Crit Care Med (2016) 0.82
Not all injection drug users are created equal: heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia. Subst Use Misuse (2008) 0.81
Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials. J Neuroimmune Pharmacol (2009) 0.80
Health-Related Quality of Life in HIV-Infected and At-Risk Women: The Impact of Illicit Drug Use and Hepatitis C on a Community Preference Weighted Measure. Med Decis Making (2013) 0.79
Cocaine promotes both initiation and elongation phase of HIV-1 transcription by activating NF-κB and MSK1 and inducing selective epigenetic modifications at HIV-1 LTR. Virology (2015) 0.76
Modeling the Effects of Morphine on Simian Immunodeficiency Virus Dynamics. PLoS Comput Biol (2016) 0.75
Cross sectional study of factors associated to self-reported blood-borne infections among drug users. BMC Public Health (2015) 0.75
Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages. Front Microbiol (2015) 0.75
Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women. Life Sci (2010) 0.75
Public health implications of antiretroviral therapy and HIV drug resistance. JAMA (1998) 4.72
Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med (1989) 4.72
Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med (1981) 3.25
An outbreak of type 4b Listeria monocytogenes infection involving patients from eight Boston hospitals. Arch Intern Med (1986) 3.12
Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care (2005) 3.06
Protocol management of dysuria, urinary frequency, and vaginal discharge. Ann Intern Med (1974) 1.64
Infusion-related phlebitis--is the in-line filter the solution? N Engl J Med (1985) 1.48
Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. J Biol Chem (1998) 1.48
Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting. Int J Tuberc Lung Dis (2011) 1.47
Adherence, compliance, and HAART. AIDS Clin Care (1997) 1.40
A randomized comparison of two instruments for measuring self-reported antiretroviral adherence. AIDS Care (2008) 1.35
Decentralised management of drug-resistant tuberculosis (MDR- and XDR-TB) in South Africa: an alternative model of care. Int J Tuberc Lung Dis (2008) 1.28
End-of-life decisions in HIV-positive patients: the role of spiritual beliefs. AIDS (1998) 1.25
Use of a quantitative cytomegalovirus (CMV) antigenemia test in evaluating HIV+ patients with and without CMV disease. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.18
Management strategies for urinary and vaginal infections. Arch Intern Med (1978) 1.16
Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262). J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.14
Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin Infect Dis (1996) 1.09
Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection? J Infect Dis (1991) 1.06
Stavudine resistance: an update on susceptibility following prolonged therapy. Antivir Ther (1999) 1.04
The dysuria-pyuria syndrome. N Engl J Med (1980) 1.02
Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa. Int J Tuberc Lung Dis (2010) 0.98
Effect of opioid dependence pharmacotherapies on zidovudine disposition. Am J Addict (2001) 0.93
Antiretroviral prophylaxis of health care workers at two urban medical centers. J Occup Environ Med (2000) 0.92
Progress in HIV therapeutics and the challenges of adherence to antiretroviral therapy. Infect Dis Clin North Am (2000) 0.91
Strategies for diagnosing vaginitis. J Fam Pract (1979) 0.90
Interaction of methadone with didanosine and stavudine. J Acquir Immune Defic Syndr (2000) 0.90
Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users. Ann Epidemiol (1994) 0.87
Demographic characteristics, drug use, and sexual behavior of i.v. drug user with AIDS in Bronx, New York. Public Health Rep (1991) 0.87
Hospice care of the intravenous drug user AIDS patient in a skilled nurse facility. J Acquir Immune Defic Syndr (1988) 0.84
Pyrogen reactions associated with the infusion of normal serum albumin (human). Transfusion (1978) 0.84
Febrile inpatients: house officers' use of blood cultures. J Gen Intern Med (1987) 0.82
Infectiousness of laryngeal tuberculosis. Am Rev Respir Dis (1976) 0.82
Effect of stavudine on human immunodeficiency virus type 1 virus load as measured by quantitative mononuclear cell culture, plasma RNA, and immune complex-dissociated antigenemia. J Infect Dis (1996) 0.82
Protocol management of dysuria, urinary frequency, and vaginal discharge. J Fam Pract (1975) 0.81
A prospective four-year follow-up of neuropsychological function in HIV seropositive and seronegative methadone-maintained patients. Gen Hosp Psychiatry (1993) 0.81
Uncertainties in the treatment of chlamydial infections in infants. N Engl J Med (1977) 0.80
Nosocomial endocarditis. Infect Control (1984) 0.80
Fever in hospitalized medical patients: characteristics and significance. J Gen Intern Med (1988) 0.78
FDA approves d4T as alternative to AZT, ddI, or ddC. Food and Drug Administration. AIDS Clin Care (1995) 0.78
AIDS research: the ethics of clinical trials. Law Med Health Care (1986) 0.77
Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med (2015) 0.77
Serologic, immunologic, and clinical features of parenteral drug users from contrasting populations. Am J Drug Alcohol Abuse (1987) 0.76
Antibiotic usage in Kupat Holim (Sick Fund) clinics. A pilot survey and evaluation. Isr J Med Sci (1979) 0.76
A prospective longitudinal study of neuropsychological and psychosocial factors in asymptomatic individuals at risk for HTLV-III/LAV infection in a methadone program: preliminary findings. Int J Neurosci (1987) 0.76
Experience with stavudine (D4T). Rev Soc Bras Med Trop (1995) 0.75
Management of common infectious diseases without a physician. Prim Care (1979) 0.75
Antiretroviral therapy in the future. Rev Soc Bras Med Trop (1995) 0.75
Prevalence of S. haematobium in the Okene area of Nigeria. West Afr Med J Niger Pract (1968) 0.75
Antiretroviral failure: a biopsychosocial approach. AIDS Clin Care (2000) 0.75
Prevention and management of infection in the catheterized patient. Urol Clin North Am (1976) 0.75
Access to HIV medical care: a roundtable. AIDS Clin Care (2000) 0.75
Investigating casual transmission of HIV. Nurs Times (1990) 0.75
Syringe and needle regulation, blood-borne disease transmission, and concern for public safety. JAMA (1997) 0.75
The acquired immunodeficiency syndrome: general overview. Int J Neurosci (1987) 0.75
Fear of AIDS. N Y State J Med (1987) 0.75
Freeze frame: a picture of the pandemic in 1996. AIDS Clin Care (1996) 0.75
Splenic abscess arising by direct extension from a perinephric abscess. Urol Radiol (1990) 0.75